Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Marini

Showing results (141-150 of 190) with videos related to

Pageof 19
Sort By:
Annals of Hematology|December 31, 2017
Outcomes of previously untreated elderly patients with AML: a propensity score-matched comparison of clofarabine vs. FLAGGianni B Scappaticci, Bernard L Marini, Victoria R Nachar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 3, 2025
Therapeutic outcomes of patients with acute erythroid leukemia treated with hypomethylating agentsTaylor Gabbard, Bernard L Marini, Kamran M Mirza, et al.
Leukemia Research|March 1, 2021
Hybrid chemotherapy regimen (FLAG-IDA-vincristine-prednisone) for acute leukemia with mixed-phenotype blastsJustin H Reid, Anthony J Perissinotti, Lydia L Benitez, et al.
Annals of Hematology|January 23, 2019
The leukemia strikes back: a review of pathogenesis and treatment of secondary AMLEdna Cheung, Anthony J Perissinotti, Dale L Bixby, et al.
Lung Cancer (Amsterdam, Netherlands)|April 25, 2006
A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapyF Cappuzzo, S Novello, F De Marinis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 31, 2019
A systematic review of outcome reporting in laser treatments for dermatological diseasesF Fransen, D C K S Tio, C A C Prinsen, et al.
The Science of the Total Environment|December 8, 2022
Hydrogeochemical and isotopic characterization of the Gioia Tauro coastal Plain (Calabria - southern Italy): A multidisciplinary approach for a focused management of vulnerable strategic systemsG Vespasiano, G Cianflone, L Marini, et al.
Blood Cells, Molecules & Diseases|August 23, 2005
A closed system for the clinical banking of umbilical cord bloodV Adami, W Malangone, E Falasca, et al.
Journal of Pediatric Hematology/Oncology|November 11, 2024
Retrospective Comparison of Targeted Anticancer Drugs Predicted by the CNS-TAP Tool Versus Those Selected by a Molecularly Driven Tumor Board in Children With DIPGHolly J Roberts, Karthik Ravi, Bernard L Marini, et al.
Leukemia & Lymphoma|December 27, 2019
Impact of a vincristine dose cap on the incidence of neuropathies with DA-EPOCH-R for the treatment of aggressive lymphomasTaylor M Weis, Bernard L Marini, Victoria R Nachar, et al.
Pageof 19

Showing results (141-150 of 190) with videos related to

Sort By:
Pageof 19
Annals of Hematology|December 31, 2017
Outcomes of previously untreated elderly patients with AML: a propensity score-matched comparison of clofarabine vs. FLAGGianni B Scappaticci, Bernard L Marini, Victoria R Nachar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 3, 2025
Therapeutic outcomes of patients with acute erythroid leukemia treated with hypomethylating agentsTaylor Gabbard, Bernard L Marini, Kamran M Mirza, et al.
Leukemia Research|March 1, 2021
Hybrid chemotherapy regimen (FLAG-IDA-vincristine-prednisone) for acute leukemia with mixed-phenotype blastsJustin H Reid, Anthony J Perissinotti, Lydia L Benitez, et al.
Annals of Hematology|January 23, 2019
The leukemia strikes back: a review of pathogenesis and treatment of secondary AMLEdna Cheung, Anthony J Perissinotti, Dale L Bixby, et al.
Lung Cancer (Amsterdam, Netherlands)|April 25, 2006
A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapyF Cappuzzo, S Novello, F De Marinis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 31, 2019
A systematic review of outcome reporting in laser treatments for dermatological diseasesF Fransen, D C K S Tio, C A C Prinsen, et al.
The Science of the Total Environment|December 8, 2022
Hydrogeochemical and isotopic characterization of the Gioia Tauro coastal Plain (Calabria - southern Italy): A multidisciplinary approach for a focused management of vulnerable strategic systemsG Vespasiano, G Cianflone, L Marini, et al.
Blood Cells, Molecules & Diseases|August 23, 2005
A closed system for the clinical banking of umbilical cord bloodV Adami, W Malangone, E Falasca, et al.
Journal of Pediatric Hematology/Oncology|November 11, 2024
Retrospective Comparison of Targeted Anticancer Drugs Predicted by the CNS-TAP Tool Versus Those Selected by a Molecularly Driven Tumor Board in Children With DIPGHolly J Roberts, Karthik Ravi, Bernard L Marini, et al.
Leukemia & Lymphoma|December 27, 2019
Impact of a vincristine dose cap on the incidence of neuropathies with DA-EPOCH-R for the treatment of aggressive lymphomasTaylor M Weis, Bernard L Marini, Victoria R Nachar, et al.
Pageof 19